The fasting blood glucose and long non-coding RNA SNHG8 predict poor prognosis in patients with gastric carcinoma after radical gastrectomy
Authors:
- 6 October 2018
- journal article
- research article
- Published by Impact Journals, LLC in Aging
- Vol. 10 (10) , 2646-2656
Abstract
This prospective study sought to evaluate the prediction of fasting blood glucose and long non-coding RNA (lncRNA) SNHG8 for the risk of gastric carcinoma mortality. A total of 217 gastric carcinoma patients underwent radical gastrectomy were included during 2012-16. The final follow-up was finished in January 2017. The aggregate hazard ratio(HR) demonstrated that poor prognosis of gastric carcinoma was associated with fasting blood glucose (HR= 1.29, P=0.037), SNHG8 expression(HR = 1.10, P= 0.009), positive distant metastasis(HR = 2.99, P= 0.020), EBV positive (HR = 3.40, P=0.002), and tumor size more than 5.0 cm (HR = 3.36, P= 0.005). In survival analysis, elevated fasting blood glucose (P =0.007) and high SNHG8 expression (P =0.007) were significantly associated with shorter survival times in gastric cancer. Significant multiplicative interaction was shown between fasting blood glucose and SNHG8 expression (chi-squared=7.81, Pmultiplicative =0.005), without statistical additive interaction. Fasting blood glucose and SNHG8 expression could predict poor prognosis after radical gastrectomy. LncRNA SNHG8 could be applied as a novel epigenetic molecular target in gastric carcinoma.Keywords
This publication has 35 references indexed in Scilit:
- Gastrointestinal cancer incidence in type 2 diabetes mellitus; results from a large population-based cohort study in the UKCancer Epidemiology, 2018
- Cancer statistics in China, 2015CA: A Cancer Journal for Clinicians, 2016
- Mutational landscape of gastric adenocarcinoma in Chinese: Implications for prognosis and therapyProceedings of the National Academy of Sciences, 2015
- Gastric Cancer: Descriptive Epidemiology, Risk Factors, Screening, and PreventionCancer Epidemiology, Biomarkers & Prevention, 2014
- Epigenetic dysregulation in Epstein-Barr virus-associated gastric carcinoma: Disease and treatmentsWorld Journal of Gastroenterology, 2014
- Gastric Cancer: Current Status of Diagnosis and TreatmentCancers, 2013
- Prospective cohort study of metabolic risk factors and gastric adenocarcinoma risk in the Metabolic Syndrome and Cancer Project (Me-Can)Cancer Causes & Control, 2012
- Diabetes and cancer I: risk, survival, and implications for screeningCancer Causes & Control, 2012
- Diabetes mellitus and risk of gastric cancerEuropean Journal of Gastroenterology & Hepatology, 2011
- Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific DeathNew England Journal of Medicine, 2011